NCT02864628View on ClinicalTrials.gov

RSV-MVA-BN Vaccine Phase I Trial, Intranasal Application in Adults.

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

September 30, 2016

Primary Completion Date

October 27, 2017

Study Completion Date

October 27, 2017

Conditions
Respiratory Syncytial Virus Infections
Interventions
BIOLOGICAL

MVA-BN-RSV

MVA-mBN294B

OTHER

Placebo

Tris Buffered Saline

Sponsors

Lead Sponsor

Bavarian Nordic
All Listed Sponsors
lead

Bavarian Nordic

INDUSTRY